INHALABLE AZTREONAM LYSINATE FORMULATION FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS

Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections, particularly gram-negative bacterial infections. Preparation of aztreonam lysinate using ±-aztreonam provides an advantageous manufacturing process and a product which has h...

Full description

Saved in:
Bibliographic Details
Main Authors LINTZ, FRANKRISTOPHE, KELLER, MANFRED, MONTGOMERY, ALAN BRUCE
Format Patent
LanguageEnglish
Polish
Published 31.10.2017
Subjects
CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES
DISINFECTION, STERILISATION, OR DEODORISATION OF AIR
HUMAN NECESSITIES
HYGIENE
MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES
MEDICAL OR VETERINARY SCIENCE
METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Aztreonam lysinate is able to be administered via inhalation. It is useful in the treatment of pulmonary bacterial infections, particularly gram-negative bacterial infections. Preparation of aztreonam lysinate using ±-aztreonam provides an advantageous manufacturing process and a product which has high purity and stability.
Bibliography:Application Number: PL20040777564T